Central pontine myelinolysis in a patient undergoing isonatric haemodialysis: the potential role of metabolic and nutritional vulnerability

Introduction: Central pontine myelinolysis (CPM) is usually associated with rapid correction of hyponatremia but may occur in normonatremic patients. Its occurrence during isonatric haemodialysis raises questions about metabolic vulnerability. Case description: A 65-year-old man receiving maintenance haemodialysis since 2020, subsequently managed with an isonatric strategy, developed progressive tremors, dizziness, gait instability, falls, and cognitive impairment. Brain magnetic resonance imaging in August 2023 revealed a central pontine lesion suggestive of CPM, which was unchanged in April 2024. Previous imaging during an ischemic stroke in 2021 showed no pontine lesion. Predialysis sodium ranged from 138 to 143 mmol/l, without documented rapid correction. Recurrent postdialysis hypokalemia (minimum 3.1 mmol/l), hypoalbuminemia (23 g/l), low prealbumin (12 mg/dl), and inflammation (C-reactive protein 153.4 mg/l) were documented. In June 2024, propranolol, potassium supplementation, and intradialytic parenteral and oral nutritional support were initiated. In July, albumin reached 37.7 g/l, prealbumin 23.6 mg/dl, and C-reactive protein 4.9 mg/l. Treatment was well tolerated. Tremors improved, and the patient regained independence. Discussion: Recurrent hypokalemia and nutritional and inflammatory abnormalities may increase susceptibility to osmotic demyelination despite limited sodium fluctuations. However, their causal contribution remains uncertain. Conclusion: CPM should be considered in haemodialysis patients with progressive neurological symptoms, even without documented hyponatremia.

Authors

Institutions

Publication Details

Journal
European Journal of Case Reports in Internal Medicine
Published
2026-11-19
DOI
https://doi.org/10.12890/2026_007628
Primary Topic
Electrolyte and hormonal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Central pontine myelinolysis in a patient undergoing isonatric haemodialysis: the potential role of metabolic and nutritional vulnerability

Tanguy GBAGUIDI, Irénée DJICONKPODE, Arriel Makembi Bunkete, Timothé Davodoun et al.
European Journal of Case Reports in Internal Medicine
Electrolyte and hormonal disorders
article

Central pontine myelinolysis in a patient undergoing isonatric haemodialysis: the potential role of metabolic and nutritional vulnerability

Tanguy GBAGUIDI, Irénée DJICONKPODE, Arriel Makembi Bunkete, Timothé Davodoun, Jonathan Muamba Mutombo, Mamadou Mouctar Diallo, Henry Botaka
article en

Abstract

Introduction: Central pontine myelinolysis (CPM) is usually associated with rapid correction of hyponatremia but may occur in normonatremic patients. Its occurrence during isonatric haemodialysis raises questions about metabolic vulnerability. Case description: A 65-year-old man receiving maintenance haemodialysis since 2020, subsequently managed with an isonatric strategy, developed progressive tremors, dizziness, gait instability, falls, and cognitive impairment. Brain magnetic resonance imaging in August 2023 revealed a central pontine lesion suggestive of CPM, which was unchanged in April 2024. Previous imaging during an ischemic stroke in 2021 showed no pontine lesion. Predialysis sodium ranged from 138 to 143 mmol/l, without documented rapid correction. Recurrent postdialysis hypokalemia (minimum 3.1 mmol/l), hypoalbuminemia (23 g/l), low prealbumin (12 mg/dl), and inflammation (C-reactive protein 153.4 mg/l) were documented. In June 2024, propranolol, potassium supplementation, and intradialytic parenteral and oral nutritional support were initiated. In July, albumin reached 37.7 g/l, prealbumin 23.6 mg/dl, and C-reactive protein 4.9 mg/l. Treatment was well tolerated. Tremors improved, and the patient regained independence. Discussion: Recurrent hypokalemia and nutritional and inflammatory abnormalities may increase susceptibility to osmotic demyelination despite limited sodium fluctuations. However, their causal contribution remains uncertain. Conclusion: CPM should be considered in haemodialysis patients with progressive neurological symptoms, even without documented hyponatremia.

European Journal of Case Reports in Internal Medicine
University of French Guiana (GF), University of Kinshasa (CD), Cliniques Universitaires de Kinshasa (CD)
Electrolyte and hormonal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon